268 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Download search resultsDownload the search results for:
Exclude Unknown | Expanded Access Studies (268 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Available Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG)
2 Available 68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors
Conditions: Carcinoid Tumors;   Islet Cell (Pancreatic NET);   Other Neuroendocrine Tumors
Intervention: Drug: 68Ga-DOTA TATE
3 No longer available Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
Condition: Metastatic Renal Cell Cancer
Intervention: Drug: Everolimus
4 No longer available Fosamprenavir Expanded Access
Condition: HIV Infection
Interventions: Drug: fosamprenavir;   Drug: Telzir®
5 Available Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention,
Condition: HIV
Intervention: Behavioral: Lifestyle Counseling
6 Approved for marketing Humanitarian Device Exemption
Condition: Dystonia
Intervention: Device: Medtronic Activa Gpi
7 No longer available Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
8 Approved for marketing A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003
Condition: Pancreatic Cancer
Intervention: Drug: OFF in experimental arm
9 No longer available Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
Condition: Parkinson Disease
Intervention: Drug: Pergolide
10 Available Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer
Condition: Gastric Cancer.
Intervention: Drug: Phase I Dose-finding Study of Sorafenib Study
11 No longer available An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
12 Available Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents
Conditions: Fanconi Anemia;   Autosomal or Sex Linked Recessive Genetic Disease;   Bone Marrow Hematopoiesis Failure, Multiple Congenital Abnormalities, and Susceptibility to Neoplastic Diseases.;   Hematopoiesis Maintainance.
Interventions: Genetic: human whole exome;   Genetic: whole genomic
13 Available Ruxolitinib for Chuvash Polycythemia
Condition: Chuvash Polycythemia
Intervention: Drug: Ruxolitinib
14 No longer available Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies
Condition: Acquired Hemophilia A
Intervention: Biological: OBI-1
15 Available Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Conditions: GBM;   Glioblastoma Multiforme
Intervention: Biological: DCVax-L
16 No longer available Single Patient Expanded Access Protocol: Metabolic Boost
Condition: Metachromatic Leukodystrophy
Intervention: Biological: Enriched Hematopoetic Stem Cell Transplant
17 No longer available Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Condition: Byler Disease
Intervention: Drug: Glycerol phenylbutyrate
18 No longer available Compassionate Use Trial for Unresectable Melanoma With Ipilimumab
Condition: Melanoma
Intervention: Drug: Ipilimumab
19 Available SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
Conditions: Cholestasis;   Growth Failure
Intervention: Drug: SMOFlipid
20 Available EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Daclatasvir;   Drug: Sofosbuvir;   Drug: Ribavirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years